BioSpace News Archive

Pharm Country

NanoViricides Provides Update, Says Company is Stable and is Moving Steadily towards Clinical Trials

NanoViricides, Inc. (the “Company”) reports that it is financially sound and that its drug candidates in the HerpeCide™ program are moving towards the clinical stage at a reasonable pace.

May 14, 2018

·

5 min read

Oklahoma Bioscience Association to Exhibit at 2018 BIO International Convention

May 14, 2018

·

1 min read

Kaneka has invested in AB-Biotics SA, a Spanish biotech company and concluded a license agreement for production and sales of its probiotics products

Kaneka Corporation (Tokyo, Japan, President: Mamoru Kadokura) has acquired a 34.8% share of AB-Biotics (“ABB”) (Barcelona, Spain, a Spanish biotech company focusing on research, development, and distribution of its own products using lactic acid bacteria).

May 14, 2018

·

2 min read

FDA

BMG Pharma: GelX® Approved in Europe for Prevention of Oral Mucositis in Cancer Patients

BMG Pharma S.r.l., an innovative specialty pharmaceutical company, is pleased to announce the European regulatory approval for its GelX product to be used for the prevention of oral mucositis.

May 14, 2018

·

2 min read

Business

Bruker Announces Quarterly Dividends

Bruker Corporation (NASDAQ: BRKR) today announced payment of a quarterly cash dividend in the amount of $0.04 per share on the Company’s common stock.

May 14, 2018

·

1 min read

Drug Development

Alkahest Announces Initiation of Two Phase 2 Clinical Trials of ALK4290 in Age-Related Macular Degeneration

Alkahest Inc. is a clinical-stage biotechnology company focused on developing innovative therapies to treat age-related diseases

May 14, 2018

·

3 min read

Policy

Ampio Provides Corporate Update

Ampio Pharmaceuticals, Inc. to address significant inflammatory conditions for which limited treatment options exist, today announced updates to shareholders that address questions recently posed to management by shareholders.

May 14, 2018

·

4 min read

Business

Complexa Appoints Francisco D. Salva Chief Executive Officer and President

Founder of Acerta Pharma to lead Complexa as it advances Phase 2 clinical development of lead compound CXA-10 in two orphan indications

May 14, 2018

·

3 min read

Drug Development

Concentric Analgesics Announces Positive Topline Results from Phase 1b Clinical Trial for CA-008 in Post-Surgical Pain

Clinically Meaningful Reductions in Pain Lasting for a Week

May 14, 2018

·

6 min read

Deals

Agilent Completes Acquisition of Genohm

Acquisition enhances Agilent’s current software portfolio, adding LIMS and workflow management, while expanding ELN capability.

May 14, 2018

·

4 min read